Sbir phase II award to via therapeutics

Ended Definitive Contract Awarded

Contract number
75N93023C00060
Awardee
Awarding agency
Obligated
$1,468,122

Award facts

Contract value 100% obligated
$1,468,122.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC
AN12 Health R&D Services; Health Care Services; Applied Research
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Austin, TX 78750, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $1.5M definitive contract to Via Therapeutics, LLC, doing business as Via Therapeutics LLC, located in Austin, Texas. The firm fixed price contract runs from September 15, 2023 through September 14, 2026 to support Via Therapeutics' Phase II award for small business innovation research related to developing new therapeutics. No subcontractors were identified.

Quick answers

Who was awarded contract 75N93023C00060?

75N93023C00060 was awarded to Via Therapeutics, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 15, 2023.

How much is contract 75N93023C00060 worth?

The government has obligated $1,468,122 on 75N93023C00060.

Was contract 75N93023C00060 competed?

The extent of competition for 75N93023C00060 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award